Recruiting An Education and Navigation Support Tool to Improve Participation in Care Coordination Among Patients With Locally Advanced, Metastatic and Unresectable Bladder Cancer and Their Caregivers NCT06414317 Conditions Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Locally Advanced Bladder Carcinoma, +13 more Locations Roswell Park Cancer Institute — Buffalo, New York, United States View Trial Details
Recruiting Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology NCT05756569 Conditions Bladder Adenocarcinoma, Bladder Squamous Cell Carcinoma, Female Urogenital Diseases, +22 more Locations Grady Health System — Atlanta, Georgia, United States Emory University Hospital Midtown — Atlanta, Georgia, United States Emory University Hospital/Winship Cancer Institute — Atlanta, Georgia, United States Emory Saint Joseph's Hospital — Atlanta, Georgia, United States View Trial Details
Active, Not Recruiting Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma NCT04940299 Conditions Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +72 more Locations M D Anderson Cancer Center — Houston, Texas, United States View Trial Details
